Along with MAPK9, PCK2, ACSL3, STMN1, CDO1, and CXCL2, SLC1A4 is potentially associated with multiple oncogenic signatures and invasive-associated signaling pathways in HCC [18]. The gene discussed is SLC1A4; the disease is hepatocellular carcinoma.